European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- 1-(4-{4-amino-7-[1-(2-hydroxyethyl)-1H-pyrazol-4-yl]t
Community Register of medicinal products
Community register of orphan medicinal products | GRANTED |
Product information |
1-(4-{4-amino-7-[1-(2-hydroxyethyl)-1H-pyrazol-4-yl]thieno[3,2-c]pyridin-3-yl}phenyl)-3-(3-fluorophenyl)urea
| EU orphan designation number: | EU/3/11/915
|
| Active ingredient: | 1-(4-{4-amino-7-[1-(2-hydroxyethyl)-1H-pyrazol-4-yl]thieno[3,2-c]pyridin-3-yl}phenyl)-3-(3-fluorophenyl)urea |
| Indication: | Treatment of acute myeloid leukaemia |
| Sponsor: | AbbVie Ltd
Maidenhead, SL6 4XE, United Kingdom |
Public summary of scientific opinion
